United Therapeutics Financial Market Data
| Last Close 14-Nov-2008 |
$90.52 |
Price/ Sales Ratio |
7.92 |
| 52-Week High |
$117.82 |
Price/ Book Ratio |
5.02 |
| 52-Week Low |
$72.55 |
Price/ Earnings Ratio |
50.57 |
| 60-Month Beta |
0.6 |
Price/ Cash Flow Ratio |
30.10 |
| Market Cap (mil.) |
$2,098.3 |
Return on Assets |
6.3% |
| Shares Outstanding (mil.) |
23.2 |
Return on Equity |
12.8% |
| Dividend Rate |
-- |
Current Ratio |
1.01 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
265 |
% Owned by Institutions |
126.0% |
| Latest Short Interest Ratio |
8.20 |
Latest Net Insider Transactions |
0.00 |
| Revenue Growth |
34.9% |
146.1% |
412.9% |
| EPS Growth |
(45.3%) |
(4.8%) |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
